Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Sniff 101 and Other Lessons

David S. Pisetsky, MD, PhD  |  Issue: April 2007  |  April 1, 2007

I startled. I had never before heard the term “sniff.” Although my hospital has discouraged abbreviations and acronyms, they nevertheless persist and, if anything, proliferate at a furious rate. Everyone is too pressed for time to spell out diabetes mellitus rather than popping in DM with two quick keystrokes. Who has the luxury of time to say “an ST elevation myocardial infarction” rather than the more familiar and benign sounding “STEMI”? STEMI sounds like a cute name for a girl rather than a catastrophic life-threatening event.

When you round with a new team, it is always good to start off with a winner, a case where—as the attending—you can show your stuff. The best circumstance is to have a case within your clinical bailiwick. With lupus, I could shine, lecturing on recent articles and asking the house staff questions for which I know the answer.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

But I did not know what a sniff was and being flummoxed is no way to start as the attending.

I wracked my brain to see if I had ever heard of a sniff. Was it a class of drugs like an ARB (angiotensin receptor blocker)? Or was it type of diagnostic test like a cath or a therapeutic intervention like TIPS (transjugular intrahepatic portosystemic shunt)?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

My silence was uneasy as I conjured possibilities for sniff. Maybe it was a sinus node fragmentator or frumtanator or something like. Alas, I could not come up with anything that corresponded to sniff.

Ten minutes into my attending work, I was ready to go down in defeat, stumped by an acronym the preciousness of time had forced into use.

My face desolate, shaking my head, I asked, “What is a ‘sniff’?”

“Oh,” the resident said, smiling in a kind but indulgent way, “a ‘sniff’ is a skilled nursing facility.”

A light went off in my head as I put two and two together. It was clear that sniff was for a pronunciation of SNF.

I was tempted to expatiate on the importance of clear communication in medicine and the hazards of using abbreviations. I decided to accept a small setback, however, and not act like an old curmudgeon.

“The sniff is a good idea,” I said, sitting upright, and then added with just a little swagger in my voice, “Make sure the BUN and hematocrit are stable so that we can transfer him quickly. His length of stay is already too long.”

Alphabet Soup

I did well for about another 10 minutes when I had to ask what “HOCUM” was. That was an entity that I used to call IHSS (idiopathic hypertrophic subaortic stenosis); its new moniker is hypertrophic obstructive cardiomyopathy.

Page: 1 2 3 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:EducationPractice Managementrheumatologist

Related Articles
    Alpha Tauri 3D Graphics / shutterstock.com

    Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis

    December 14, 2020

    Research in The New England Journal of Medicine has opened new avenues for exploring the pathophysiology of disease flares in rheumatoid arthritis.1 Through longitudinal genomic analysis, researchers have identified a naive B cell signature prior to rheumatoid arthritis flares, as well as a type of mesenchymal cell, that may play an important role in flare…

    Revisiting Rounds: Lessons from the General Medicine Ward

    April 1, 2010

    Lessons from the general medicine ward

    Study Finds Correlations Between Synovial Tissue & Gene Expression

    October 18, 2018

    Rheumatoid arthritis (RA) can be typed, grouped and categorized in different ways, and subgroup identification could help guide future research and treatment strategies based on which subtypes respond to which treatment. A new study explored an approach associating gene expression profiling with histologic analysis of synovium samples to define RA subtypes and then examined how…

    Updates to Axial Spondyloarthritis Guideline

    September 5, 2019

    A 2019 update of the ACR’s previous clinical practice guideline on axial spondyloarthritis is now available online. Lead investigator Michael Ward, MD, shares advice for implementing the guideline updates, including those related to sequencing and tapering biologics, and knowing when to obtain images.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences